Recent performance snapshot for STAAR Surgical

STAAR Surgical (STAA) has drawn attention after a strong share price move, with the stock up about 26% over the past month and about 78% over the past 3 months.

At the current share price of US$32.47, STAAR Surgical’s recent 30 day share price return of 26.5% and 90 day share price return of 78.4% contrast with a 5 year total shareholder return that is down 77.8%, suggesting momentum has picked up after a difficult longer term period.

If this kind of rebound has your attention, it could be a good moment to broaden your search and check out 20 top founder-led companies

With STAAR Surgical’s share price sharply higher, recent revenue and net income growth reported, and the stock trading above one analyst price target, a key question is whether there is still a buying opportunity here or whether the market is already pricing in future growth.

Most Popular Narrative: 54% Overvalued

Analysts following STAAR Surgical see a fair value of about $21.11 per share, well below the recent $32.47 close. This sets up a pointed debate around expectations.

STAAR Surgical has significant cash reserves and no debt, providing a strong financial base to manage the current challenges, adjust production temporarily, and invest selectively in growth initiatives, which could help stabilize earnings and support upside potential if conditions improve. At the same time, the business faces increased scrutiny around execution in key markets, with investors closely watching how management allocates this financial flexibility.

It is worth examining what earnings path, margin lift, and valuation multiple are built into that $21.11 figure, and how much depends on China and refractive procedure trends.

Result: Fair Value of $21.11 (OVERVALUED)

However, weak consumer demand and sell through uncertainty in China, along with cost cutting that could constrain investment in growth, still hang over the current narrative.

Next Steps

With the stock’s recent surge and mixed signals on valuation, it helps to see the positives for yourself and act while sentiment is focused. To understand why some investors are still optimistic, review the company’s 1 key reward

Looking for more investment ideas?

If STAAR Surgical has sharpened your focus, do not stop here. Expand your watchlist now so you are not late to the next opportunity.

• Target potential value opportunities by scanning 49 high quality undervalued stocks that combine quality fundamentals with appealing pricing.
• Prioritise resilience by reviewing 67 resilient stocks with low risk scores that score well on financial strength and volatility.
• Broaden your opportunity set by checking the screener containing 21 high quality undiscovered gems that most investors may still be overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.